Abstract:The heterogeneity of Hepatocellular Carcinoma (HCC) poses a barrier to effective treatment. Stratifying highly heterogeneous HCC into molecular subtypes with similar features is crucial for personalized anti-tumor therapies. Although driver genes play pivotal roles in cancer progression, their potential in HCC subtyping has been largely overlooked. This study aims to utilize driver genes to construct HCC subtype models and unravel their molecular mechanisms. Utilizing a novel computational framework, we expanded the initially identified 96 driver genes to 1192 based on mutational aspects and an additional 233 considering driver dysregulation. These genes were subsequently employed as stratification markers for further analyses. A novel multi-omics subtype classification algorithm was developed, leveraging mutation and expression data of the identified stratification genes. This algorithm successfully categorized HCC into two distinct subtypes, CLASS A and CLASS B, demonstrating significant differences in survival outcomes. Integrating multi-omics and single-cell data unveiled substantial distinctions between these subtypes regarding transcriptomics, mutations, copy number variations, and epigenomics. Moreover, our prognostic model exhibited excellent predictive performance in training and external validation cohorts. Finally, a 10-gene classification model for these subtypes identified TTK as a promising therapeutic target with robust classification capabilities. This comprehensive study provides a novel perspective on HCC stratification, offering crucial insights for a deeper understanding of its pathogenesis and the development of promising treatment strategies. Dividing highly heterogeneous HCC into molecular subtypes with similar characteristics is crucial for personalized anti-tumor therapies. Although driver genes play pivotal roles in cancer progression, their potential in HCC subtyping has been largely overlooked. In this work, we developed a multi-omics network-based stratification algorithm that utilizes patient mutation data and requires smaller computational resources for subtype assignment. Through this algorithm, we categorized HCC into two subtypes, CLASS A and CLASS B. Using multi-omics and single-cell data, we identified differences between these subtypes in gene expression, methylation, immune infiltration, and other aspects. Beyond subtype characterization, our study established a robust clinical prediction model (https://mike-wang-bjut.shinyapps.io/DynNomapp_HCC_Sutypes/) incorporating subtype information and typical clinical features, enabling precise survival predictions. Finally, we developed a high-performing machine learning classifier for our subtype. Analyzing this classification model and reviewing previous experimental papers, we identified TTK as a potential diagnostic marker and therapeutic target specific to our subtypes. In conclusion, our research offers a novel perspective on HCC stratification, which is crucial for a deeper understanding of its pathogenesis and developing promising treatment strategies.

Molecular Subtyping of Hepatocellular Carcinoma: A Step Toward Precision Medicine

Emerging Biomolecules for Practical Theranostics of Liver Hepatocellular Carcinoma.

Identification of Molecular Subtypes for Integrated Multi-Omics Analysis for Use in Guiding Precision Medicine in Hepatocellular Carcinoma.

Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges

Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment

Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis

Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma

Integrated Multiple “-Omics” Data Reveal Subtypes of Hepatocellular Carcinoma

Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology

Subtyping for pancreatic cancer precision therapy.

Precision Medicine for Hepatocellular Carcinoma: Driver Mutations and Targeted Therapy

Translational Medicine in Hepatocellular Carcinoma

Research Advances in Molecular Classification for Precision Diagnosis and Treatment of Hepatocellular Carcinoma

Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making

The advanced development of molecular targeted therapy for hepatocellular carcinoma

Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma

Comprehensive molecular classification predicted microenvironment profiles and therapy response for hepatocellular carcinoma

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma

[Progress of Molecular Subtypes of Colorectal Cancer].

Integrated Multiomic Analysis Reveals Comprehensive Tumour Heterogeneity and Novel Immunophenotypic Classification in Hepatocellular Carcinomas

Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective